Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ALNY - Alnylam Pharmaceuticals, Inc.
796 M
LAST VALUE
13.22%
2 YEAR CAGR
15.78%
5 YEAR CAGR
40.18%
10 YEAR CAGR